Recently, we designed a tumor‐targeted transmorphic phage/AAV (RGD4C.TPA) gene delivery system that we propose to apply for targeted TNFα therapy against pediatric medulloblastoma.9 The gene discussed is TNF; the disease is medulloblastoma.